SequelSEC

CERUS CORP CERS

Surgical & Medical Instruments & Apparatus · CIK 0001020214 · Fiscal year ends 1231

Revenue
$233.80M
Fiscal year ended 2025-12-31
Operating income
-$8.68M
Fiscal year ended 2025-12-31
Free cash flow
$1.11M
Fiscal year ended 2025-12-31

CERUS CORP (CERS) reported revenue of $233.80M and net income of -$15.63M for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from CERUS CORP’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

CERUS CORP income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$233.80M$201.32M$186.80M$188.32M$159.52M$114.25M$93.77M$76.05M$51.33M$39.28M
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailable$41.16M$33.42M$31.63M$22.53MUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$44.42M$28.80MUnavailable
Operating income-$8.68M-$14.22M-$30.05M-$34.08M-$48.94M-$58.33M-$66.23M-$54.99M-$57.53M-$61.45M
Net income-$15.63M-$20.92M-$37.49M-$42.78M-$54.37M-$59.86M-$71.24M-$57.56M-$60.58M-$62.91M
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 190.59Mshares 184.56Mshares 180.27Mshares 176.54Mshares 171.28Mshares 163.95Mshares 139.83Mshares 131.66Mshares 108.22Mshares 101.83M
Pretax income-$15.28M-$20.76M-$37.32M-$42.34M-$54.06M-$59.57M-$70.98M-$57.34M-$56.70M-$62.73M
Income tax expense$354.00K$205.00K$325.00K$488.00K$319.00K$284.00K$263.00K$229.00K$3.89M$175.00K
Diluted EPS$-0.08$-0.11$-0.21$-0.24$-0.32$-0.37Unavailable$-0.44$-0.56$-0.62
Selling, general & administrative$80.91M$75.89M$75.52M$83.34M$81.29M$67.02M$66.20M$56.84M$52.62M$48.96M
General & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

CERUS CORP balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Cash & equivalents$19.96M$20.27M$11.65M$35.58M$48.76M$36.59M$34.99M$28.86M$13.68M$22.56M
Total assets$221.86M$200.92M$197.75M$218.09M$237.50M$221.42M$165.54M$163.46M$98.24M$103.48M
Current assets$174.38M$152.02M$144.44M$170.14M$187.10M$183.43M$128.11M$146.90M$89.90M$94.10M
Total liabilities$156.89M$144.02M$144.30M$149.53M$151.88M$117.61M$108.48M$78.94M$59.30M$45.69M
Current liabilities$100.80M$63.61M$67.52M$117.06M$78.56M$59.97M$50.34M$52.68M$23.13M$26.89M
Total equity incl. NCI$64.96M$56.90M$53.44M$68.56M$85.62M$103.81M$57.05M$84.52M$38.94M$57.79M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$56.10M$38.15M$39.87M$29.00M$26.79M$23.25M$19.49M$13.54M$14.46M$12.53M
Accounts receivable$30.37M$29.78M$35.50M$34.43M$25.13M$21.17M$16.88M$8.75M$12.42M$6.87M
Goodwill$1.32M$1.32M$1.32M$1.32M$1.32M$1.32M$1.32M$1.32M$1.32M$1.32M
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$28.01M$21.70M$23.84M$33.00M$35.61M$24.21M$22.18M$18.60M$10.97M$8.59M

Cash flow

CERUS CORP cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Operating cash flow$4.84M$11.36M-$43.17M-$25.62M-$33.92M-$41.81M-$65.50M-$31.25M-$52.24M-$53.53M
Capital expenditures$3.73M$2.84M$4.60M$2.00M$910.00K$1.62M$8.94M$1.14M$353.00K$563.00K
Investing cash flow-$6.16M-$8.13M$8.62M$8.46M$12.69M-$49.56M$28.18M-$43.85M$421.00K-$19.92M
Financing cash flow$231.00K$4.96M$10.67M$4.19M$34.29M$91.78M$43.49M$92.75M$43.00M$24.57M
Net change in cash-$761.00K$8.00M-$24.00M-$13.69M$12.14M$1.48M$5.83M$17.66M-$8.81M-$48.89M
Stock-based compensation$22.87M$22.87M$20.27M$24.46M$23.57M$18.03M$13.31M$10.39M$9.36M$8.06M
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$1.43M$1.86M$2.60M$2.98M$3.15M$3.11M$2.40M$1.44M$1.81M$1.82M

Derived

CERUS CORP derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Free cash flow$1.11M$8.52M-$47.76M-$27.62M-$34.83M-$43.43M-$74.43M-$32.39M-$52.59M-$54.09M
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable58.4%56.1%Unavailable
Operating margin-3.7%-7.1%-16.1%-18.1%-30.7%-51.1%-70.6%-72.3%-112.1%-156.5%
FCF margin0.5%4.2%-25.6%-14.7%-21.8%-38.0%-79.4%-42.6%-102.5%-137.7%
SBC / revenue9.8%11.4%10.9%13.0%14.8%15.8%14.2%13.7%18.2%20.5%
Current ratio1.73x2.39x2.14x1.45x2.38x3.06x2.55x2.79x3.89x3.50x
Revenue YoY growth16.1%7.8%-0.8%18.1%39.6%21.8%23.3%48.2%30.7%Unavailable
Net margin-6.7%-10.4%-20.1%-22.7%-34.1%-52.4%-76.0%-75.7%-118.0%-160.2%
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenue1.6%1.4%2.5%1.1%0.6%1.4%9.5%1.5%0.7%1.4%
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CERS in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-07-30View SEC filing
10-Q · Filed 2026-04-30View SEC filing
10-K · Filed 2026-03-02View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-05View SEC filing
10-Q · Filed 2025-05-01View SEC filing

Companies in the same industry

Reconciliation checks needing review

3 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

gross profit bridgeinconsistent2020-12-31

Withheld: gross profit could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2019-12-31

Withheld: gross profit could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2016-12-31

Withheld: cost revenue, gross profit could not be reconciled with the rest of this filer’s statement.